Jeremiah Deneve
@jigdeneve
Followers
689
Following
5K
Media
255
Statuses
1K
Surgical Oncologist at UNC, Dad, lover of history and struggling triathlete🏊♂️🚴🏻♂️🏃🏻♂️
Chapel Hill, NC
Joined February 2018
Honored to have @UFSurgery Dr. Gil Upchurch give the inaugural Jeffrey Scott Brody Endowed Lecture honoring former @UNCSurgery Chair Nathan Womack. Inspiring, heartfelt talk to a packed audience!
0
1
3
Honored to speak and meet so many patients, caregivers and families at the #PMPPALS annual patient forum in Charlotte. Informative, compassionate and high yield information on what to expect and questions to ask when considering HIPEC surgery from @WakeSurgonc @UNCSurgery
0
1
12
.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews
0
5
16
Thrilled to be part of 3rd Annual #GI symposium @UKMarkey @UKSurgOnc @LexingtonKyGov @AmCollSurgeons @AcademicSurgery @UnivSurg
2
5
23
In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky
1
7
17
Superb UNC-Duke Surg Onc journal club on Gastric/GEJ cancers. Excellent discussion and presentations by @SocSurgOnc 1st & 2nd yr CGSO Fellows! So much to learn from these talented superstars! @DukeSurgOnc @UNCSurgery @YehlabUNC @PSpanheimer @globalsurgallie @michael_lidsky
1
6
15
#ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: https://t.co/xBChV6GALe
0
9
20
To close out #Appendix Cancer Awareness Month.. Read more about it and hear from our expert Dr. Benjamin Powers @UMGCCC. https://t.co/rAFy1M2YNv
@acpmpresearch @MarylandSurg
webmd.com
Appendix cancer refers to growth that develops from the cells of the appendix. Understand if appendix cancer is rare, how it is diagnosed, its stages, and prognosis.
0
6
12
Thrilled to see our work featured in the gastric cancer chapter of Shackelford’s. Honored to contribute to such a landmark publication and grateful to be part of this incredible project. @ElsevierConnect
@SyedAAhmad5
@AuroraPryor
@WiscSurgery @UNCSurgery
2
5
30
Amazing trip to #MexicoCity for the 90th @gastromx meeting. Grateful to see old friends, make new friends, talk about intra-arterial therapy for hepatic malignancies, and learn from international experts! Thank you to @domcai777 for the incredible hospitality!
0
3
34
The CT scan doesn’t lie! New video for #medstudents and residents who want to learn how to review a pancreas protocol CT scan. @UCincySurg @UMNSurgery @USFsurgery @UTSWSurgeryLife @SyedAAhmad5 @JBMatthews @FlavioRochaMD @ChildersBg
https://t.co/GDO6C9qyIQ
0
18
54
Excited to listen and learn from our very own @YehlabUNC @UNCSurgery
SSAT Research Committee Webinar: "Precision Medicine in Gastrointestinal Surgery" 🖥️ Learn how personalized approaches are transforming care for cholangiocarcinoma & colorectal liver metastases—from biomarkers to surgical strategies. Register now: https://t.co/HFdklCMBYf
0
0
4
The X-less Sean Dineen is an expert leader of the Peritoneal Surface Malignancy program at @MoffittNews He and @MikeWach_MD take outstanding care of patients with their multidisciplinary team. Honored to work with him for our #CGSO fellows. @SocSurgOnc
Appendix cancer is rare, but cases are rising, especially among younger generations. For years, Tatiana’s symptoms were dismissed as something minor. But a routine hernia surgery revealed the unexpected: appendix cancer that had silently spread. Her message now? Listen to your
3
7
31
Peter J. Allen, MD, has been named as the next chair of the Duke Department of Surgery.
medschool.duke.edu
Peter J. Allen, MD, a nationally known surgical oncologist and leader in cancer care, has been named the new chair of the Department of Surgery in the School of Medicine, effective August 25, 2025.
6
17
141
Excited for @PeterAllenMD to become the next Chair @DukeSurgery . Also grateful for Dr Allan Kirk’s leadership for over a decade.
Peter J. Allen, MD, has been named as the next chair of the Duke Department of Surgery.
0
4
38
This is a great meeting for anyone who treats patients with regional therapies for peritoneal disease, melanoma, and advanced hepatic malignancies. @SocSurgOnc
The Advanced Cancer Therapies Committee invites you to submit abstracts for the ACT 2026 Meeting. All cancer care professionals are strongly encouraged to share their scientific work! Showcase your research in Fort Lauderdale: https://t.co/uMm64uUDGo
0
5
21
Join us for this upcoming webinar! Explore management of sarcomatosis & metastatic GIST, including the role of cytoreduction +/- HIPEC. Learn about patient selection, timing & outcomes. Register now: https://t.co/cy2oCoikYD
0
9
27
It’s not goodbye, it’s see you at @SocSurgOnc/@AHPBA! We’re so proud of our graduating #CGSO and #HPBsurgery fellow, Dr. Michelle Ju. What a star! We know she’s going to have a wonderful career @UWSurgery @UWHPBSurgery 💫 😷 🔪
1
5
30
Honored to host @bermar01 @FoxChaseSurgOnc for our inaugural endowed lecture in the Department of Surgery @FoxChaseCancer learning from the ultimate #Mentor @SocSurgOnc @AmCollSurgeons @TempleHealth @WeillCornell @AmBdSurg @AcademicSurgery
1
7
28